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1 Introduction 
Open innovation (OI), a term promoted by Chesbrough in his book of 2003, describes 
how companies have shifted from so-called ‘closed innovation’ processes towards a more 
open way of innovating. In recent years scholarly interest in the relationship between OI 
and firm performance has increased (Gassmann et al., 2010; Mazzola et al., 2012; 
Spithoven, 2013). The question of how openness influences the capacity of firms to 
innovate and the ability to obtain higher economic returns is one of the main issues of OI 
research, as well as of this paper. Following the conceptualisation of Chesbrough (2003), 
researchers differentiate between three processes of OI: inbound, outbound and coupled. 
Inbound process refers to the purposive inflows of knowledge and regards the technology 
exploration and innovation activities to capture and benefit from external sources of 
knowledge. Inbound process can be implemented by adopting so-called OI inbound 
practices such as in-licensing, research institution collaborations, purchasing of scientific 
services, etc. Outbound process concerns the establishment of relationships with external 
partners with the purpose of bringing ideas to market faster than by internal development. 
The outbound process can be implemented by adopting so-called OI outbound practices 
such as out-licensing, spin-off, supply of scientific services, etc. Finally, coupled process 
refers to co-innovation with complementary partners through structured cooperation such 
as alliances and joint ventures. In the coupled process companies combine the inbound  
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process, to gain external knowledge, with the outbound process, to bring ideas to market  
and, in doing so, jointly develop and commercialise innovation. Coupled process can be 
implemented by adopting so-called OI coupled practices such as co-patenting, strategic  
alliances, etc. A few years after the concept of OI was introduced, researchers started 
looking for empirical evidences validating the effectiveness of OI processes. This paper 
aims at contributing to this stream of research. Specifically, we identify two points of 
weakness within the state of the art and we will try to fill these gaps. 
First, most of the previous literature investigates the effect of inbound, outbound, and 
coupled innovation practices separately with respect to different dimensions of 
performance. Some researches bring evidences of the positive impact of specific OI 
practices on innovation performance; others, conversely, demonstrate the negative impact 
on innovation performance. The same can be said for the impact of such OI practices on 
financial performance. Not considering the concurrent effect of a given OI practice on 
both financial and innovation performance would not actually help managers in making 
the right decision about what portfolio of OI practices to adopt. For this reason, the  
first research objective of this paper is to make a contribution in this direction by 
investigating the concurrent effect of OI practices on both performance dimensions, 
economic-financial and innovation. 
Second, most of the literature investigates the effect of different levels of OI adoption 
on performance (e.g. the open innovation breadth and depth). Several authors consider 
both the number/type of partners with which the company collaborates and the 
number/type of phases of the innovation process that the company opens to external 
contributions; this determines the degree of openness of a company (Laursen and Salter, 
2006; Lazzarotti and Manzini, 2009). This is not actually helpful for the manager who 
has to select the right OI practice (or set of practices) to better achieve specific objectives. 
Motivated by this consideration, the second research objective of this paper is to explore 
the impact of single and specific OI practices on performance, instead of just the degree 
of openness. 
Summing up, this paper, by achieving the two above-mentioned goals, provides some 
important managerial implications because it contributes to a better understanding of how 
a mix of practices, which opens the company R&D process beyond its boundaries might 
influence at the same time and in different ways the innovation outcomes and the 
economic-financial returns. 
The context of this study is the biopharmaceutical industry; the data are based on  
120 companies listed in the NASDAQ biotechnology index (NBI). We found few 
contributions in OI literature that explain the adoption of OI practices in the 
biopharmaceutical industry (Bianchi et al., 2011). Despite this little attention, we argue 
that the biopharmaceutical industry, because of its uniqueness, may offer important 
intuitions to analyse the effects of the OI practices on firm performance. 
The rest of the paper is structured as follows. After the literature analysis and the 
research motivations, we develop the theoretical framework in Section 3. Sections 4 and 
5 respectively present the research methods and results of the empirical analysis. 
Theoretical and managerial implications are discussed in Section 6, while conclusions 
and opportunities for further researches are reported in the final section. 
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2 Literature review 
Through a systemic literature review of empirical studies published between 2003 and 
2014, we examine 60 scientific papers that empirically investigate the role of the OI 
processes in explaining innovation and financial performance. For the purposes of our 
research, we categorise and summarise in Table 1 these papers according to two criteria: 
typology of performance and OI processes. 
2.1 Criterion 1: typology of performance 
We find 42 papers dealing exclusively with the effect of OI processes on innovation 
performance and 14 papers dealing exclusively with economic-financial performance. In 
our review, we find only four papers dealing with the effect of OI practices on both kinds 
of performance. Such papers are underlined in Table 1. However, they adopt aggregate 
measures for OI adoption, and they only focus mainly on the inbound process. The paper 
by Spithoven et al. (2010) investigates the impact of two aggregate constructs  
that measure the level of inbound OI adoption that are ‘inter-firm linkages’ and  
‘inter-organisational linkages’. Similarly, Hwang and Lee (2010) investigate the 
influence of the breadth and the depth of the external knowledge sources: the breadth of 
the external technology sources, a concept introduced by Laursen and Salter (2006), is 
computed as the sum of 13 external sources, i.e. inbound practices. The same can be said 
for the depth, that is the weighted sum of the same practices by their importance. Gronum 
et al. (2012) evaluate the collaboration activities of the firms as an aggregate measure by 
considering the number of network ties engaged by nine different actors. Specifically, 
based on longitudinal data from 1,435 small and medium enterprises, the authors show a 
positive relation between collaboration activities and economic performance and 
collaboration activities and innovation performance. Recently, Cheng and Huizingh 
(2014), in a survey of 223 Asian service firms, developed and tested a comprehensive 
measurement scale for OI that captures in one measure the entire range of OI activities, 
including inbound, outbound, and coupled activities. Their final measure of OI comprises 
ten items and indicates to what extent a firm has implemented these three open 
innovation activities. Their results indicate that performing OI activities is positively 
related to several dimensions of innovation and financial performance: new 
product/service innovativeness, new product/service success, customer performance, and 
financial performance. 
2.2 Criterion 2: OI processes 
Following the considerations of Chesbrough (2003) and Gassmann and Enkel (2004) we 
group these 60 papers into the three basic OI processes: inbound, outbound and coupled. 
Most of the scholars investigate in depth the effect of practices belonging to the inbound 
process on firm performance. In literature, the effect of outbound and coupled processes 
on performance is definitively less investigated. Moreover, we notice that, as in  
Criterion 1, the majority of the empirical works investigate the impact of OI practices on 
performance by testing the effect of aggregate measures of OI adoption level. For 
example, in the study of Kang and Kang (2009), the extent of using R&D collaborations 
is measured by managers’ perceptions of the total contribution coming from ten different 
collaboration partners. Hung and Chiang (2010), to assess the company’s inclination to 
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utilise external ideas and profit from their innovation, develop a multi-item construct 
named ‘OI proclivity’. There are just a few papers that test the impact of a specific OI 
practice on a specific performance measure. However, these papers do not explore the 
concurrent effect of specific OI practice on both financial and innovation performance. 
For example, Wadhwa and Kotha (2006) study the link between the specific practice of 
making corporate venture capital investments and innovation outcomes. Similarly, Tsai 
(2009) examines the relationships between different types of collaborations with different 
partners (suppliers, customers, competitors, and universities) and product innovation 
performance. Three main findings emerge from the analysis of literature on OI and 
performance. First, researches mainly focus on investigating the effect of inbound 
process on firm performance, while disregarding the effect of outbound and coupled 
processes (with few exceptions). Second, most researches deal with aggregate measures 
of OI practices and do not consider the effect of a specific practice on performance. 
Third, with very few exceptions, researches do not consider in their analysis innovation 
and economic-financial performance dimensions concurrently. This paper aims at filling 
these gaps in the OI literature and provides interesting theoretical and managerial 
suggestions. 
Table 1 Literature analysis on OI and firm performance 
 Criterion 1 
Inbound Outbound Coupled 
C
ri
te
ri
on
 2
 
In
no
va
tio
n 
pe
rf
or
m
an
ce
 
Chang et al. (2012) Cheng and Huizingh (2014) Cheng and Huizingh (2014) 
Cheng and Huizingh (2014) Inauen and  
Schenker-Wicki (2012) 
Faems et al. (2005) 
Chiang and Hung (2010)  Fey and Birkinshaw (2005) 
Ebersberger et al. (2012)  Lin et al. (2012) 
Fey and Birkinshaw (2005)  Love and Mansury (2007) 
Foss et al. (2011)  Neyens et al. (2010) 
Grimpe and Kaiser (2010)  Nieto and  
Santamaria (2007) 
Gronum et al. (2012)  Suh and Kim (2012) 
Huang and Rice (2009)  Vega-Jurado et al. (2009) 
Hwang and Lee (2010)   
Inauen and  
Schenker-Wicki (2011) 
  
Kang and Kang (2009)   
Kim and Park (2010)   
Lasagni (2012)   
Laursen and Salter (2006)   
Li and Tang (2010)   
Love and Mansury (2007)   
Love et al. (2013)   
Mention and  
Asikainen (2012) 
  
Nieto and Rodriguez (2011)   
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Table 1 Literature analysis on OI and firm performance (continued) 
 Criterion 1 
Inbound Outbound Coupled 
C
ri
te
ri
on
 2
 
In
no
va
tio
n 
pe
rf
or
m
an
ce
 
Parida et al. (2012)   
Salge et al. (2012)   
Sampson (2007)   
Santamaria and  
Surroca (2011) 
  
Spithoven et al. (2010)   
Suh and Kim (2012)   
Svetina and Prodan (2008)   
Tomlinson (2010)   
Tsai (2009)   
Tsai and Chang (2008)   
Tsai and Wang (2007a)   
Tsai and Wang (2007b)   
Tsai and Wang (2009)   
Tsai et al. (2011)   
Un et al. (2010)   
Vega-Jurado et al. (2009)   
Wadhwa and Kotha (2006)   
Wang et al. (2012)   
Zeng et al. (2010)   
Zhou and Li (2012)   
Ec
on
om
ic
-fi
na
nc
ia
l p
er
fo
rm
an
ce
 
Aschhoff and  
Schmidt (2008) 
Belderbos et al. (2010) Belderbos et al. (2010) 
Bapuji et al. (2011) Cheng and Huizingh (2014) Cheng and Huizingh (2014) 
Belderbos et al. (2004) Hung and Chou (2013) Faems et al. (2010) 
 Lichtenthaler (2011)  
Belderbos et al. (2006) Lichtenthaler (2009) Lin and Wu (2010) 
Belderbos et al. (2010) Lichtenthaler and  
Ernst (2012) 
 
Cheng and Huizingh (2014)   
Gronum et al. (2012)   
Hung and Chiang (2010)   
Hung and Chou (2013)   
Hwang and Lee (2010)   
Lin and Wu (2010)   
Litchtenthaler and  
Ernst (2012) 
  
Sisodiya et al. (2013)   
Spithoven et al. (2010)   
Wu et al. (2013)   
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3 Hypotheses development 
3.1 Hypothesis on inbound OI 
Prior research suggests that a firm can advance its innovation performance by interacting 
with different partners, primarily including suppliers, customers, competitors, and 
research organisations (Hung and Chiang, 2010; Laursen and Salter, 2006). For example, 
several scholars find confirmation that collaboration with suppliers is beneficial for a 
firm’s innovation because of the combination of complementary capabilities and the 
common goals between firm and suppliers (Hwang and Lee, 2010; Tsai, 2009). Laursen 
and Salter (2006) find that innovation performance increases with both the breadth and 
depth of external search, i.e. with the diversity of external information sources, such as 
suppliers and customers and their intensity of use. Moreover, several scholars find that 
collaboration with research institutes and universities positively affect product innovation 
performance (Hung and Chiang, 2010; Tsai, 2009); indeed, universities and research 
institutes have systems and mechanisms that facilitate access to new and complex 
knowledge. Along with the positive effect of inbound OI on the innovativeness of the 
firm, much research has claimed that the role of external acquisition of knowledge has a 
negative effect on the innovation output of firms (Inauen and Schenker-Wicki, 2011). 
There may be multifaceted reasons behind this negative relationship, including the 
inadequate or insufficient absorptive capacity (Cohen and Levinthal, 1990) of firms to 
absorb knowledge and technologies emerging in other industries, or the drainage of 
resources that the acquisition of external knowledge creates. 
Besides impacting on innovation performance, some empirical works (Aschhoff and 
Schmidt, 2008; Gronum et al., 2012) show that collaboration with external partners tends 
to be beneficial for the firm, not only in terms of innovation, but also in terms of financial 
performance. For instance, Inauen and Schenker-Wicki (2011) reveal that openness 
towards universities in R&D processes has a positive impact on the percentage of 
innovative product sales over total sales. In addition to the positive effect of inbound OI 
on financial outcomes, researchers such as Belderbos et al. (2010) suggest the possibility 
of a negative effect of these practices on financial performance. Indeed, although 
collaborative R&D activities might reduce technical risks and costs, engaging in R&D 
collaborations with external partners might introduce relational risks and increase 
coordination costs (Das and Teng, 1998). To mitigate such risks companies require  
time-consuming contract negotiations or the implementation of costly monitoring 
mechanisms. Moreover, because of the presence of cultural and organizational 
differences among different partners it may be necessary to make relational investments 
in order to facilitate coordination. 
Following such considerations, we expect a significant and concurrent effect of 
inbound OI practices on both innovation and economic-financial performance. However, 
we aim at investigating such effect, practice by practice, and do not consider aggregate 
measures of inbound OI adoption level. For this reason, we state the first hypothesis of 
the model. 
Hypothesis 1 A given inbound open innovation practice significantly and 
concurrently influences both innovation and economic-financial 
performance. 
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3.2 Hypothesis on outbound OI 
The process of outbound OI has being increasingly considered as a strategic activity by 
firms, who can profit from their own innovations without investing in complementary 
assets. Through various contractual forms (e.g. out-licensing agreements, spin-offs, or 
technology sales) firms try to externally leverage their technological knowledge to 
generate additional revenues (Lichtenthaler and Ernst, 2007). Prior empirical studies on 
the outbound OI process focus on the effects of these activities on financial performance 
(Lichtenthaler, 2009; Belderbos et al., 2010). Lichtenthaler (2009) addresses the 
relationship between outbound open R&D strategies, licensing-out among others, and 
firm performance; by using data from 136 industrial firms, his results show that a positive 
relationship exists between outbound strategies and firm financial outcomes. Apart from 
licensing-out, any knowledge asset may be divested through a spin-off, and this increases 
the financial outcomes of the firm (Chiaroni et al., 2010). Where patents are ineffective 
or technology does not match with the strategic core business, companies can develop 
policies to finance or found their tacit knowledge and thus actively participate in the 
success of their spillovers (Lichtenthaler and Ernst, 2007). Along with the positive effect, 
outbound OI arrangements may also have a negative effect on financial performance 
(Lichtenthaler, 2011). By transferring to external competitors valuable and competitively 
relevant technological knowledge, the firm’s relative technological position may 
deteriorate through the increase of competition in its own market. As a result, this 
increase of competition may lead to profit dissipation effects in a firm’s business 
segment. These negative effects may outweigh the positive financial effect of generating 
licensing revenues, so that the overall effect of outbound OI practices could become 
negative on firm performance. 
While monetary compensation is the main objective in a vast majority of external 
technology commercialisation, non-monetary incentives also guide a firm to open its 
boundaries. The commonly acknowledged non-monetary objective for external 
knowledge exploitation is gaining access to another company’s technology portfolio 
(Lichtenthaler, 2009). Here, the aim is to engage in cross-licensing agreements for 
applying external exploitation efforts to forward external acquisition efforts. While 
outbound process of external knowledge provides great financial opportunities, there is 
also the risk of negative effects on innovation performance. Managers that decide to 
license out their Intellectual Property or divesting knowledge assets certainly increase 
short short-term profits, thus meeting analysts’ expectations and stakeholders’ pressure, 
but, on a long-range horizon, may negatively affect a firm’s internal innovation process 
(Lichtenthaler, 2009). From a long-term perspective these practices may weaken the 
specific R&D capabilities of a firm, leading to a lower innovation performance. 
Following such considerations, we expect a significant and concurrent effect of 
outbound OI practices on both innovation and economic-financial performance. Again, 
we aim at investigating such an effect practice by practice and do not consider aggregate 
measures of outbound OI adoption level. For this reason, we state the second hypothesis 
of the model. 
Hypothesis 2 A given outbound open innovation practice significantly and 
concurrently influences both innovation and economic-financial 
performance. 
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3.3 Hypothesis on coupled OI 
Coupled process refers to co-innovation with complementary partners through structured 
inter-firm relationships such as alliances and joint ventures. R&D inter-organisational 
collaborations enable firms to scan their environment for new windows of opportunity 
and technologies. A significant number of scholars investigate the relationship between 
R&D inter-firm collaborations and firm innovation outcomes, showing how technological 
collaborative networks, R&D and manufacturing alliances among others, are of crucial 
importance in achieving a higher degree of novelty in product innovation (Faems et al., 
2005; Love and Mansury, 2007). Collaborative patents (co-patents) are defined as patents 
with more than one assignee. Co-patents are useful indicators of coupled OI practices 
since they reflect a fraction of the inter-firm’s collaborative relationships (Lin et al., 
2012). The co-patenting processes ask for collaboration lasting throughout the whole 
innovation process, exploration and exploitation, until the utilisation of the invented 
technology toward the market. By developing co-patents, companies improve both 
innovative and financial performance since they reduce costs and lead times of new 
patent development, enhancing the technological quality and market adaptability of 
innovation outputs. Besides positively impacting on innovation performance, inter-firm 
collaborations also negatively affect the efficiency of a firm’s innovation performance. 
With a sample of 2,456 alliances formed from 143 biopharmaceutical firms, George et al. 
(2001) find that vertical alliances are negatively related to the number of developed 
patents. 
Although R&D inter-organisational collaborations might increase financial outcomes, 
they introduce relational risks, due to opportunistic behaviours, and increase coordination 
costs needed to implement monitoring mechanisms (Faems et al., 2005). Based on a 
study of 68 R&D-intensive firms, Belderbos et al. (2010) suggest that the potential 
advantages of strategic alliances for technological activities might not compensate for the 
potential disadvantages, such as the incurred increase in coordination costs. In contrast to 
inbound OI processes, coupled processes imply that the company also needs to share the 
rewards with its collaborating partners. 
Thus, the collaboration might increase the probability of generating new ideas, 
successfully raising innovation and financial performance, but at the same time it might 
substantially limit the ability of the firm to appropriate the value of such activities. 
Following such considerations, we expect a significant and concurrent effect of 
coupled OI practices on both innovation and economic-financial performance and we 
state the third hypothesis of the model. 
Hypothesis 3 A given coupled open innovation practice significantly and 
concurrently influences both innovation and economic-financial 
performance. 
4 Method 
4.1 Sample and data collection 
The hypotheses describing the influence of OI practices on both innovation and 
economic-financial performance are tested on a sample of biopharmaceutical companies 
listed on the NASDAQ stock market, specifically the NBI subset. Despite a limited 
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number of OI researches into the biopharmaceutical industry, this industry is an early 
pioneer of OI (Bianchi et al., 2011; Chiaroni et al., 2007). In recent decades the 
biopharmaceutical industry has been faced with many challenges that have changed how 
to organise companies’ innovation activities. First of all, while a typical R&D process 
extends up to 13 years, only one out of 10,000 molecules becomes a product suitable for 
the market (Bianchi et al., 2011). Second, markets for pharmaceutical products tend to 
become more fragmented, leading to an increased risk of market failure. In addition, the 
number of new drug approvals is constantly declining, while R&D expenditures are 
increasing due to the high investments in new drug discovery technologies and more 
complex clinical studies. As a response to these challenges, biopharmaceutical firms have 
started to rethink their innovation activities, focusing on new modes to organise the R&D 
processes that go beyond their firm’s boundaries. Thus, these features make NBI 
companies an appropriate target for the study of the impact of OI practices on firm 
performance. 
We consider cross-sectional data of 128 NBI firms, registered on the NASDAQ from 
2001 to 2010. We gather data from the public annual reports of NBI companies. 
Specifically, since several researches (Nadkarni and Narayanan, 2007) have revealed that 
the 10-K model is a much more complete source of information for management research 
than the annual report, we collect the 10-K form of NBI firms’ annual reports. Moreover, 
the 10-K form is an appropriate source of information for our kind of analysis  
since it allows us to collect both financial and innovation data. We remove eight 
biopharmaceutical companies from the initial sample of 128 NBI companies, since they 
have missing data on their 10-K form. Therefore, we conduct the analysis on a sample of 
120 companies. 
4.2 Dependent variables 
In the innovation management literature, we find a long history of conflict within the 
theme of measuring firms’ innovation performance. Scholars have employed several 
kinds of measures to capture firms’ innovative performance (Hagedoorn and Cloodt, 
2003), such as R&D inputs, patent counts, patent citations, counts of new product 
introductions, or more specific survey-based measurements (Ahuja, 2000; Bae and 
Gargiulo, 2004; Soh, 2003). Our choice to measure the firm’s innovation outcome as the 
total number of patents developed by the firm throughout 2001–2010 is basically due to 
the following rationales. 
First, patent-based measures provide a relatively fair measure of new knowledge. 
Indeed, by definition patents are required to describe something novel and not obvious; 
an invention, to be patented, must be something not already known from prior knowledge 
(Walker, 1995). Thus, patents provide a good measure of technologically new knowledge 
that is the core concept of OI research. 
Second, several studies have used patents as a measure of innovation performance 
(Ahuja, 2000; Gilsing et al., 2008; Padula, 2008; Phelps, 2010; Salman and Saives, 2005; 
Schilling and Phelps, 2007; Vanhaverbeke et al., 2009). Thus, following this long history 
in innovation management literature we use the number of patents as a proxy of the 
firm’s innovation performance. 
Third, since the importance of patenting differs greatly across industries, a further 
rationale underlying our choice is the research context we select to test our hypotheses. 
Indeed, our hypotheses are tested on a sample of 120 biopharmaceutical companies listed 
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on the NASDAQ stock market, specifically the NBI subset. It is well known that 
biopharmaceutical firms are more specialised in patent development and 
commercialisation then pursuing the entire innovation path from early discovery to 
product development (Rothaermel and Deeds, 2004). 
Fourth, the availability of patent data motivates the use of a patent-based measure of 
innovation in this study. Indeed, electronic access to patent data through the US Patent 
and Trademark Office databases has increased the use of patents in industrial and 
academic research (Walker, 1995). 
We operationalise the innovation performance variable considering the total number 
of patents (Patents) developed by the firm throughout 2001–2010. To construct the patent 
measure, we use patent data from the U.S. Patents and Trademarks Office (USPTO), 
which is a comprehensive and publicly available database of US patents. Following the 
same considerations as Lin et al. (2012), we gather data on patents obtained in the USA, 
since this represents the largest market for the biopharmaceutical industry, and thus 
companies generally patent there before in any other countries. 
In more detail, we operationalise the patent variable by using a simple patent count as 
a measure of innovation outcome. We made this choice, which is in contrast to some 
scientific literature that suggests using patent citation instead of patent count, for several 
reasons. Indeed, even if innovation performance is better captured by patent citations, we 
believe that citations are accumulated with age and therefore this measure might be 
biased towards old patents. More specifically, in the case of the biopharmaceutical 
industry, because the companies are mostly young (as are their patents), the number of 
patent citations would not be a good measure for innovation performance. Also, 
companies tend to have different policies toward the patenting issue, due to the estimated 
costs for issuing patents. For instance, for a pharmaceutical company such as Roche these 
costs must be insignificant, while for a small biotechnology firm, such as Acadia, this 
expenditure could represent a significant investment. For these reasons, in this particular 
industry, we believe that patent counts adequately capture the innovation performance of 
biopharmaceutical companies. 
With regard to the financial implications of OI practices, accounting measures are 
typically used in literature as indicators of performance; for example, Lichtenthaler 
(2009) uses a financial indicator of profitability, i.e. return on sales. We analyse the 
effects of OI practices on economic-financial performance by adopting a common 
measure of profitability, i.e. the revenue. In particular, following previous works on OI 
and performance (Spithoven et al., 2010), we measure the growth of the firm’s revenue 
(Growth of revenue) from 2001 to 2010. Recent literature recognises revenue growth as a 
more direct measure of firm competitiveness together with income growth and profit 
margin, rather than financial variables, such as stock valuation (Lee, 2006). Moreover, in 
his work, Ferrary (2011) adopts the company’s revenue as a proxy for activities of 
exploitation of new knowledge. It is possible to assert that the choice of revenue is 
consistent with our conceptual framework since revenue growth reflects the firm’s 
capability to convert its new knowledge into exploitable innovations. 
Moreover, even if the data we collect for the revenue growth are from 2001 to 2010 
and thus include the years of the economic crisis of 2009, this is not an issue. Indeed, 
cyclical factors, such as the economic crisis of 2009, which may affect companies’ 
financial performance, are spread over all firms in the sample, so it is possible to consider 
their overall effect as null. Since we select all the companies listed on the NBI, the 
possible differences due to the economic crisis are annulled within the sample. 
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4.3 Independent and control variables 
As regards the independent variables, we consider several practices as inbound, outbound 
and coupled OI-oriented by basically reviewing the most relevant literature on OI that has 
already associated each of these practices to the inbound, outbound and coupled 
categories. Besides self-explanatory OI practices such as licensing agreements,  
co-patenting, purchase and supply of technical and scientific services (Bianchi et al., 
2011), we also identify and name two practices ‘Platform biotech firms’ and 
‘Institutional collaboration’ by using the name of the ‘collaborator’ instead of the 
agreement because we observed a large amount of OI practices of the ‘inbound’ kind 
with these types of collaborators. So, for example, we also count and collect the number 
of Platform biotech companies the firm collaborates with for knowledge inflow. 
Moreover, we also consider the inbound OI practice ‘Venture capital’, which the 
traditional literature has considered as a source to acquire financial resources. We include 
this practice within the category of inbound following the considerations of several 
authors that advance the idea that venture capitals are likely to be a source of knowledge 
and highly valuable innovative ideas rather than just a source of financial resources 
(Benson and Ziedonis, 2009; Dushnitsky and Lenox, 2005; Ferrary, 2011; Wadhwa and 
Kotha, 2007). For example, Dushnitsky and Lenox (2005) suggest how venture capital 
programmes are important instruments for accessing external valuable knowledge (inflow 
of knowledge – inbound) that increases firm innovation rates. Thus, following these 
considerations, we include venture capital within the inbound category. 
We report in Table 2 the 14 OI practices (six inbound, five outbound, and three 
coupled) identified in our research, together with the name of the authors that 
investigated them in previous papers. Also, in Table 2 we report the measures we use for 
operationalising them and the short names (Variable) we use in the following statistical 
analysis. We derive information about how many times each company was involved in 
each OI practice from its 10-K forms for 2001–2010. 
Table 2 OI practices, literature, variable names and constructs 
OI practices Literature Variables Measurements  (for the period 2001–2010) 
Inbound practices 
In-licensing Tsai (2009) In-licens Number of intellectual property 
rights of other organisations, such as 
patents, the firm bought or used 
Tsai and Wang (2009) 
Institutional 
collaboration 
Aschhoff and  
Schmidt (2008) 
Inst coll Number of university, research 
centre, public and non-profit 
organisation collaborations for 
knowledge inflow in which  
the firm engaged 
Belderbos et al. (2006) 
Hwang and Lee (2010) 
Laursen and  
Salter (2006) 
Platform  
biotech firm 
Chiaroni et al. (2010) Plat 
biotech 
Number of specialised firms 
focused on the development  
and commercialisation of new 
biotech-based technologies with 
which the firm collaborated for 
knowledge inflow 
Chiaroni et al. (2007) 
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Table 2 OI practices, literature, variable names and constructs (continued) 
OI practices Literature Variables Measurements  (for the period 2001–2010) 
Inbound practices 
Purchasing of 
scientific services 
Chiaroni et al. (2010) Purch serv Number of scientific  
services the firm purchased 
Venture capital Benson and  
Ziedonis (2009) 
Vent cap Number of research studies 
supported by venture capitalists  
in which the firm engaged Dushnitsky and  
Lenox (2005) 
Wadhwa and  
Kotha (2006) 
Acquisition Vanhaverbeke  
et al. (2002) 
Acquis Number of acquisitions in which the 
firm engaged 
Outbound practices 
Out-licensing Lichtenthaler (2011) Out-licens Number of patents and copyrights 
the firm sold or offered to other 
organisations 
Lichtenthaler and  
Ernst (2007) 
Divest Lee and Madhavan 
(2010) 
Divest Number of divisions, business units 
and product lines the firm divested 
Spinoff Chesbrough and 
Rosenbloom (2002) 
Spinoff Number of divisions, business units 
and product lines the firm spun off 
Chesbrough (2003) 
Supply of 
scientific services 
Chiaroni et al. (2010) Supp serv Number of scientific  
services the firm sold 
External 
technology 
commercialisation 
Lichtenthaler (2005) Ext comm Number of agreements for 
commercialisation and distribution 
in which the firm engaged 
Lichtenthaler and  
Ernst (2007) 
Kutvonen (2011) 
Coupled practices 
Co-patent Lecocq and  
Van Looy (2009) 
Co-patent Number of patents the firm  
co-developed with other 
organisations or universities Lin et al. (2012) 
Strategic alliance Belderbos et al. (2010) Strat all Number of R&D alliances and 
manufacturing alliances for  
co-manufacturing aims in  
which the firm engaged 
Faems et al. (2005) 
Fey and Birkinshaw 
(2005) 
Lin et al. (2012) 
Strategic joint 
venture 
Gassmann and  
Enkel (2004) 
Strat JV Number of R&D JV and 
manufacturing JV for  
co-manufacturing aims  
in which the firm engaged 
Sampson (2007) 
To control for firm-level factors that might influence a firm’s innovation and  
economic-financial performance, we include in the analysis several control variables. 
First of all, we control for the age of the firm (Age) and for firm size (Size), calculated by 
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the log of the total number of employees. Moreover, we control for the degree of 
globalisation (Glob) as the percentage of sales on the international market and for the 
number of trademarks developed (Trad). Finally, we control for the R&D expenditures 
(R&D exp) as the slope of R&D expenses in the last ten years. 
5 Results 
Table 3 provides the descriptive statistics, with minimum and maximum values, means, 
and standard deviations of the variables, while Table 4 displays the correlation matrix. 
Table 3 Descriptive statistics 
  Mean Std. dev. Min Max 
1 Age 22.40 12.49 6 124 
2 Size 5.73 1.31 2.92 10.02 
3 Trad 22.08 32.22 0 255 
4 Glob 1.77 0.85 1 5 
5 R&D exp 12.18 33.21 –31 255 
6 In-licens 22.35 17.99 0 76 
7 Inst coll 14.85 17.12 0 103 
8 Plat biotech 1.53 4.37 0 35 
9 Purch serv 1.90 3.98 0 25 
10 Vent cap 2.16 3.77 0 12 
11 Acquis 2.32 3.32 0 18 
12 Out-licens 25.91 30.84 0 214 
13 Divest 0.95 1.34 0 5 
14 Spinoff 0.20 0.95 0 9.0 
15 Supp serv 2.20 3.85 0 11 
16 Ext comm 18.80 23.97 0 233 
17 Co-patent 3.28 7.30 0 50 
18 Strat all 37.91 R32.06 0 238 
19 Strat JV 1.97 5.93 0 50 
20 Patents 46.60 78.82 0 527 
21 Growth of revenue 67.72 213.04 –24.35 1588.4 
To control for the multicollinearity problem among variables, we check the variance 
inflation factors (VIFs). The highest individual VIF score among all the variables is 2.71, 
whereas the mean VIF score is 1.53, thus multicollinearity among variables is not a 
problem in our analysis (Lin et al., 2012). 
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Table 4 Correlation matrix 
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The first dependent variable of this study, i.e. the total number of patents, is a countable 
variable, and takes only non-negative integer values. Prior studies assert that the Poisson 
regression model provides a natural model for modelling such data (Lin et al., 2012). 
However, in our case the underlying assumption of the Poisson model of equality of the 
mean and variance of the dependent variable is violated, leading to inefficient Poisson 
estimates. Consequently, in line with other works in OI literature, we utilise a negative 
binomial regression analysis to overcome the problem of over-dispersion (Lin  
et al., 2012; Wadhwa and Kotha, 2006). Whereas, as regards to the second dependent 
variable, the growth of revenue, since it is a continuous quantitative measure we use an 
OLS regression model. 
Table 5 Negative binomial for innovation performance and OLS for financial performance 
Independent  
variable 
Dependent variable –  
Patents 
Dependent variable –  
Growth of revenue 
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Controls         
Age –0.02* 
(0.01) 
–0.02** 
(0.00) 
–0.02**
(0.00) 
–0.01 
(0.00) 
–0.01†
(0.00) 
–0.01†
(0.01) 
–0.01† 
(0.01) 
–0.02* 
(0.01) 
Size 0.65*** 
(0.11) 
0.76*** 
(0.11) 
0.73***
(0.11) 
0.36*** 
(0.11) 
–0.01†
(0.00) 
–0.01 
(0.00) 
–0.01 
(0.00) 
–0.01 
(0.00) 
Trad 0.00 
(0.00) 
0.00 
(0.00) 
0.01* 
(0.03) 
0.01*** 
(0.03) 
–0.14 
(0.13) 
–0.13 
(0.12) 
–0.10 
(0.12) 
0.02 
(0.14) 
Glob –0.27* 
(0.14) 
–0.23† 
(0.15) 
–0.37**
(0.14) 
–0.41***
(0.14) 
0.28† 
(0.17) 
0.32† 
(0.18) 
0.30† 
(0.18) 
0.23 
(0.19) 
R&D exp –0.50 
(0.16) 
–0.00 
(0.16) 
–0.05 
(0.15) 
0.42* 
(0.21) 
0.51* 
(0.24) 
0.50* 
(0.23) 
0.52* 
(0.22) 
0.49† 
(0.29) 
Inbound         
In-licens  –0.01 
(0.00) 
–0.01† 
(0.00) 
–0.01***
(0.00) 
 0.02**
(0.00) 
0.02*** 
(0.00) 
0.02*** 
(0.00) 
Inst coll  0.01** 
(0.00) 
0.01* 
(0.00) 
0.01* 
(0.00) 
 0.00 
(0.00) 
0.00 
(0.00) 
0.01† 
(0.00) 
Plat biotech  0.01 
(0.03) 
–0.01 
(0.03) 
–0.05** 
(0.02) 
 0.03 
(0.02) 
0.03 
(0.02) 
0.04† 
(0.02) 
Purch serv  0.09** 
(0.03) 
0.07** 
(0.03) 
0.05* 
(0.02) 
 0.00 
(0.02) 
0.00 
(0.02) 
0.01 
(0.02) 
Vent cap  –0.02 
(0.03) 
–0.01 
(0.02) 
–0.04† 
(0.02) 
 –0.05 
(0.03) 
–0.03 
(0.03) 
–0.03 
(0.04) 
Acquis  –0.10** 
(0.03) 
–0.10**
(0.03) 
–0.04 
(0.03) 
 –0.10 
(0.03) 
–0.01 
(0.03) 
–0.01 
(0.04) 
Notes: ***p < .001, **p < .01, *p < .05, †p < .10;  
Robust standard errors are in parentheses. 
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Table 5 Negative binomial for innovation performance and OLS for financial performance 
(continued) 
Independent  
variable 
Dependent variable –  
patents 
Dependent variable –  
growth of revenue 
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Outbound         
Out-licens   0.01* 
(0.00) 
0.00 
(0.00) 
  0.01 
(0.00) 
0.01* 
(0.00) 
Divest   0.01 
(0.08) 
0.02 
(0.07) 
  –0.19* 
(0.09) 
–0.17† 
(0.09) 
Spinoff   –0.06 
(0.12) 
–0.22† 
(0.13) 
  –0.14* 
(0.96) 
–0.05 
(0.09) 
Supp serv   0.03 
(0.02) 
0.03 
(0.02) 
  –0.01 
(0.03) 
–0.01 
(0.03) 
Ext comm   0.00 
(0.00) 
–0.02* 
(0.00) 
  –0.01 
(0.03) 
0.01 
(0.00) 
Coupled         
Co-patent    0.08*** 
(0.02) 
   –0.23† 
(0.14) 
Strat all    0.01*** 
(0.00) 
   –0.01† 
(0.00) 
Strat JV    0.01 
(0.01) 
   –0.01 
(0.02) 
Numobs 120 120 120 120 120 120 120 120 
Wald χ2  
and R2 
42.32*** 54.60*** 77.45*** 107.23*** 0.08*** 0.18*** 0.22*** 0.25*** 
Notes: ***p < .001, **p < .01, *p < .05, †p < .10;  
Robust standard errors are in parentheses. 
Table 5 presents the results of the regression analysis estimated by negative binomial 
regression to explain the innovation performance, and the OLS regression results to 
explain the economic-financial performance. As regards the innovation performance, 
Model 1 is the base-line model, including only the control variables. Model 2 shows the 
result of regression, analysing the effects of six inbound OI practices on innovation 
performance, while Model 3 includes the main effects of five outbound OI practices. 
Finally, Model 4, the full model, adds the variables related to the three coupled OI 
practices. Looking at Wald χ2 statistics, the addition of these variables in Model 2,  
Model 3, and Model 4 increases the overall model fit as compared with Model 1 (Δχ2 = 
64.91). 
As regards the economic-financial performance, in Model 5 we enter only the control 
variables and we find that they can explain low amount of the variance (R2 = 0.08). The 
main effects of inbound OI practices on financial performance are entered in Model 6. 
After these six variables are included, there is a certain improvement of the model fit  
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(R2 = 0.18). In Model 7, we introduce the main effects of outbound practices. The 
introduction of these five variables improves the model fit (R2 = 0.22). Finally in  
Model 8, we introduce the variables related to the coupled practices. This increases the 
model fit (R2 = 0.25). We use Models 4 and 8 to examine the theoretical expectations 
addressed earlier and to interpret the results. 
Several control variables are significantly related to innovation performance. Size is 
positively associated with the number of patents, indicating that bigger NBI companies 
report better innovation outcomes. The international orientation (Glob) has a negative 
impact on firm innovation; this result indicates that the higher the capacity of NBI firms 
to reach new markets, the lower the innovation outcomes. The coefficients of Trad and 
R&D exp are positively related with the innovation performance measure; this confirms 
that, even in the biopharmaceutical industry, such variables influence patents’ 
development. Age is not significant. Concerning financial performance, only Age and 
R&D exp are significant. Age is negatively associated with the growth of the revenue 
indicating that younger NBI companies report better economic-financial performance 
than older ones. R&D expenditure (R&D exp) is positively associated with the growth of 
revenue. 
Hypothesis 1 receives support for the practices In-licens, Inst coll and Plat biotech. In 
particular, the amount of in-licensing agreements the firm engages in is positively related 
to the growth of revenue while negatively related to the number of patents. The amount 
of institutional collaborations the firm engages in is positively related both to the growth 
of revenue and the number of patents. Finally, the amount of collaborations with the 
platform biotech firms is positively related to the growth of revenue while negatively 
related to the number of patents. On the other hand, Purch serv is positively related only 
to the number of patents, while Vent cap is negatively related to them. No inbound 
practices are significantly related only to the economic-financial measure. 
Hypothesis 2 does not receive support since the variables that are significant in  
Model 4 are not significant in Model 8. Specifically, Spin-off and Ext comm are 
negatively related only to the innovation measure, while Out-licens and Divest are 
positively related only to the economic-financial measure. 
Hypothesis 3 receives support for two practices, explicitly Co-patents and Strat all. In 
particular, it emerges that the number of co-patents the firm develops with other 
organisations is positively related to the number of patents while it is negatively related to 
the growth of revenue. Similarly, the number of strategic alliances the firm engages in is 
positively related to the number of patents while it is negatively related to the growth of 
revenue. No coupled practices are significantly related to only one of the performance 
measures of our model. 
6 Findings and implications 
The first important finding is that although a lot of research works argue that OI 
processes bring benefits to both innovation and economic-financial performance, we find 
that only five out of 14 investigated OI practices affect both such performance 
dimensions. Also, their concurrent effects have either a different or same sign. 
Specifically, as shown in the matrix of Table 6, we find that institutional collaborations 
affect positively both kinds of performance. 
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Table 6 OI practices affecting both innovation and financial performance 
 Innovation performance 
Positive effect Negative effect 
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ct
 • Institutional collaboration (I) • In-licensing (I) 
• Platform biotech firms (I) 
N
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iv
e 
ef
fe
ct
 • Co-patent (C) 
• Strategic alliances (C) 
 
As regards the second quarter of the matrix, the two inbound OI practices, in-licensing 
and platform biotech firms, affect both kinds of performance but they have a discordant 
effect; indeed, they negatively affect the innovation performance while positively 
influencing the economic-financial performance. Also the two coupled OI practices,  
co-patents and strategic alliances, seem to impact on both the dimensions with conflicting 
effects. Specifically, as reported in the third quarter of the matrix, they positively affect 
the innovation performance while negatively influencing the financial performance. 
Finally, not one of the previous 14 OI practices seems to have a concurrent negative 
effect on both innovation and economic-financial performance. 
Based on this finding we provide empirically explanations on how a given OI 
practice, while bringing advantages from an economic-financial point of view, may lead 
to innovation performance deterioration, or vice versa. Thus, considering the concurrent 
effect of OI practices on both such performance dimensions may help managers in 
making the right decision about what portfolio of OI practices to adopt, depending on 
their strategic objectives. 
Second, although a lot of empirical papers demonstrate that a given level of adoption 
of inbound, outbound or coupled OI processes is correlated to improvements in 
innovation or economic-financial performance, we find that when considering specific OI 
practice adoption, this is not always true. There are some OI practices (no matter whether 
they are inbound, outbound or coupled OI) that do not affect performance at all. We 
resume these results in the matrix of Table 7. 
Apart from practices belonging to the first quarter, which have already been discussed 
in Table 6, it is of great interest to analyse the OI practices belonging to the other three 
quarters. In the second quarter of the matrix, the two outbound OI practices, out-licensing 
and divest, are significant in the economic-financial models, while they are not 
significant in innovation performance. On the contrary, as reported in the third quarter of 
the matrix, the two inbound OI practices, purchasing of scientific service and venture 
capital, and the two outbound OI practices, spin-off and external technology 
commercialisation, are significant in the innovation models while they are not significant 
in economic-financial performance. Finally, we find three practices (acquisition, supply 
of scientific services, and strategic joint ventures) whose adoption is not significant with 
respect to both the performance dimensions. Consequently, exploring the impact of single 
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and specific OI practice on performance, instead of just OI adoption intensity level, 
brings different and new conclusions. Thus, once again, a punctual analysis of the 
significance of each OI practice on both kinds of performance will help managers in 
designing their portfolio of practices to better achieve specific objectives. 
Table 7 Significance of effect of OI practices on performance 
 Innovation performance 
Significant Non-significant 
Ec
on
om
ic
-fi
na
nc
ia
l p
er
fo
rm
an
ce
 
Si
gn
ifi
ca
nt
 
• In-licensing (I) 
• Institutional collaboration (I) 
• Platform biotech firms (I) 
• Co-patents (C) 
• Strategic alliance (C) 
• Out-licensing (O) 
• Divest (O) 
N
on
-s
ig
ni
fic
an
t • Purchasing of scientific services (I) 
• Venture capital (I) 
• Spinoff (O) 
• External technology 
commercialisation (O) 
• Acquisition (I) 
• Supply of scientific service (O) 
• Strategic joint venture (C) 
Moreover, having investigated 14 different OI practices separately leads us to argue that 
using aggregate measures of OI implementation might bring new findings concerning 
inbound, outbound and coupled OI processes. In fact, our results show that different 
practices belonging to the same OI process (inbound, outbound, coupled) affect firm 
performance in very opposite ways. For example, collaborations with platform biotech 
firms for inflowing knowledge and purchasing of scientific services are usually 
considered together in a single aggregate measure of inbound OI (Bianchi et al., 2011; 
Chiaroni et al., 2010). We argue that, when considered separately, one may observe that 
they affect innovation performance in an opposite way. The amount of platform biotech 
firms’ collaborations is negatively related to the number of patents (while the number of 
purchase of services is positively related). Aggregate measures of OI practices might not 
evidence such discordant effects by counterbalancing them. 
7 Conclusions 
On the basis of a sample of 120 biopharmaceutical companies, the present paper explores 
a topic that is crucial both for managers and practitioners, that is the relationship between 
the adoption of OI practices and innovation and economic-financial performance. To the 
best of our knowledge, to date no scholars have investigated the simultaneous influence 
of practices belonging to inbound, outbound and coupled OI processes on both 
innovation and economic-financial performance. Surprisingly, our findings show that 
considering OI practices separately, not aggregately, produces new and different 
conclusions related to the concurrent effect of each of them on both economic-financial 
and innovation performance. This opens up the way for new research development about 
the concept of wideness, besides the already known breadth and depth dimensions of OI 
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(Laursen and Salter, 2006), meaning the contemporary adoption of OI practices (even 
belonging to the same or different OI process – inbound, outbound and coupled) and its 
impact on performance. Second, our findings have interesting implications for managers 
who are adopting OI strategies for improving innovation and economic-financial 
performance. Indeed, when designing OI strategy the manager should be well acquainted 
with the whole portfolio of possible practices she/he may adopt. The results of such a 
paper, in fact, could help managers not only in selecting the most appropriate practice 
(existing literature already suggests this), but also in evaluating the concurrent effects of 
these sets of practices on both economic-financial and innovation performance. 
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